Revenues at publicly traded biotechnology companies jumped 17 percent nationwide, while the number at locally traded biotechs climbed 20 percent, according to a global biotech report by Ernst & Young LLP...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99